Clinical Profiling and Therapeutic Outcomes in Diabetic Foot Ulcer

Abstract

Diabetes is one of the chronic causes of diabetic foot ulcers. Diabetes was expected to affect 131 million people globally in 2000, with a projected increase to 366 million by 2030. Diabetes foot ulcers are thought to account for around 20% of hospital admissions among diabetic individuals. The purpose of this study is to assess the disease burden in terms of clinical outcomes and surgical intervention of diabetic foot ulcer patients at our hospital, including debridement and amputation. Between December 2020 and April 2021, 50 diabetic foot ulcer patients were admitted to the Department of General Surgery at the NRI Institute of Medical Sciences and Hospital in Mangalagiri, chinnakakani, Krishna dist., Andhra Pradesh, India. The male to female ratio was around 1.7. The age range 56-65 years had the highest number of patients. Most of the patients had history of diabetes in between 5 to 10 years. Surgical complications were more common in male patients than female patients. Staphylococcus aureus was the most common organism found in culture report. The mainstay of treatment was a conservative approach that included diabetes control with human insulin, antibiotics, and wound debridement. The surgical procedure opted were split skin grafting, disarticulation and below knee amputation in few cases. In our study, there was no mortality. The success of diabetic foot ulcer management depends on prevention, early assessment and treatment by multidisciplinary approach.